ALTRAPHARMA Invest ApS: Financial statements 2025
CVR: 34483884
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766. The solvency ratio was 71.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -88,915
- Profit/Loss
- DKK -84,944
- Equity
- DKK 103,766
- Total Assets
- DKK 145,186
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -89 t. | -85 t. | 104 t. | 1 |
| 2024 | - | -43 t. | 87 t. | 89 t. | 0 |
| 2023 | - | -67 t. | -67 t. | 2 t. | 0 |
| 2022 | - | -172 t. | -484 t. | 69 t. | 1 |
| 2021 | - | -76 t. | -146 t. | 554 t. | 0 |
Official annual report
How creditworthy is ALTRAPHARMA Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 26, 2025, ALTRA 14 ApS is registered as an owner of ALTRAPHARMA Invest ApS with an ownership share of 66%.
As of November 26, 2025, is registered as an owner of ALTRAPHARMA Invest ApS with an ownership share of 25%.
As of October 21, 2025, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has stepped down as auditor of ALTRAPHARMA Invest ApS.
On October 21, 2025, the company changed its name from ALTRAPHARMA ApS to ALTRAPHARMA Invest ApS.
As of March 25, 2025, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has been appointed auditor of ALTRAPHARMA Invest ApS.
As of March 25, 2025, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of ALTRAPHARMA Invest ApS.
About ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.